Relationship between the m-FI 11 score and 2-year survival in octogenarians undergoing colorectal cancer resection

被引:1
|
作者
Ari, Kaso [1 ,6 ]
Iqbal, Muhammad Rafaih [2 ]
Crane, Jasmine [4 ]
Borucki, Joseph [5 ]
Nunney, Ian [3 ]
Hernon, James [2 ]
Stearns, Adam [2 ]
机构
[1] Norfolk & Norwich Univ Hosp, Core Surg Trainee, Norwich, England
[2] Norfolk & Norwich Univ Hosp, Gen Surg, Norwich, England
[3] Univ East Anglia, Norwich Med Sch, Norwich, England
[4] Basildon Hosp, Core Surg Trainee, Basildon, England
[5] James Paget Univ Hosp, Gen Surg, Yarmouth, England
[6] Norfolk & Norwich Univ Hosp NHS Trust, Norwich, Norfolk, England
来源
ANNALS OF MEDICINE AND SURGERY | 2024年 / 86卷 / 01期
关键词
colorectal; frailty; m-FI; outcomes; FRAILTY; COMPLICATIONS; SURGERY; ASSOCIATION; ONCOLOGY;
D O I
10.1097/MS9.0000000000001453
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction:The modified Frailty Index (m-FI) offers a simple scoring tool, predicting short-term outcomes in elderly colorectal cancer (CRC) patients. However, links between m-FI scores and 2-year postoperative mortality in octogenarian CRC resection patients remain underexplored. A streamlined frailty index can aid in preoperative assessments to identify elderly patients who are likely to live longer after curative resection surgery to then tailor postoperative care. Our study aims to assess the association between m-FI scores and 2-year postoperative mortality in elderly CRC surgery patients.Methods:A retrospective analysis was conducted on a cohort of consecutive patients aged older than or equal to 80 years who underwent colorectal cancer resection at a tertiary referral centre between 2010 and 2017. The m-FI-11 scores less than or equal to two denoted the non-frail category, whereas m-FI scores equal to or exceeding 3 were categorised as frail. The primary outcome measure was defined as 2-year all-cause mortality.Results:A total of 337 patients were studied. The 2-year overall survival rate was 83% with an overall median survival time of 84 months (95% CI: 74-94 months). Patients with m-FI scores less than or equal to 2 had a 2-year survival rate of 85% and a median survival time of 94 months (95% CI: 84-104 months). Conversely, patients with m-FI scores greater than or equal to 3 had a 2-year survival rate of 72% and a median survival time of 69 months (95% CI: 59-79 months). An m-FI score greater than or equal to 3 showed a hazard ratio of 1.73 (95% CI: 0.92-3.26, P=0.092) for 2-year mortality compared to an m-FI score less than or equal to 2.Conclusion:Higher m-FI scores significantly correlate with an increased 2-year mortality risk among octogenarian CRC resection patients. This highlights the potential of the m-FI as a preoperative tool for identifying patients likely to survive longer post-surgery. Its integration aids in tailored postoperative care strategies, ensuring efficient recovery to functional baselines in this cohort.
引用
收藏
页码:62 / 68
页数:7
相关论文
共 50 条
  • [1] The relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancer
    Richards, C. H.
    Leitch, E. F.
    Horgan, P. G.
    Anderson, J. H.
    McKee, R. F.
    McMillan, D. C.
    BRITISH JOURNAL OF CANCER, 2010, 103 (09) : 1356 - 1361
  • [2] The Relationship Between Patient Physiology, the Systemic Inflammatory Response and Survival in Patients Undergoing Curative Resection of Colorectal Cancer
    Richards, Colin
    Leitch, Fiona
    Horgan, Paul G.
    McMillan, Donald C.
    GASTROENTEROLOGY, 2010, 138 (05) : S860 - S860
  • [3] Relationship Between Preoperative Comorbidity, Systemic Inflammatory Response, and Survival in Patients Undergoing Curative Resection for Colorectal Cancer
    C. S. D. Roxburgh
    J. J. Platt
    E. F. Leitch
    J. Kinsella
    P. G. Horgan
    D. C. McMillan
    Annals of Surgical Oncology, 2011, 18 : 997 - 1005
  • [4] The relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancer
    C H Richards
    E F Leitch
    P G Horgan
    J H Anderson
    R F McKee
    D C McMillan
    British Journal of Cancer, 2010, 103 : 1356 - 1361
  • [5] Relationship Between Preoperative Comorbidity, Systemic Inflammatory Response, and Survival in Patients Undergoing Curative Resection for Colorectal Cancer
    Roxburgh, C. S. D.
    Platt, J. J.
    Leitch, E. F.
    Kinsella, J.
    Horgan, P. G.
    McMillan, D. C.
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (04) : 997 - 1005
  • [6] The relationship between tumour proliferative activity, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer
    Canna, K.
    Hilmy, M.
    McMillan, D. C.
    Smith, G. W.
    McKee, R. F.
    McArdle, C. S.
    McNicol, A. -M.
    COLORECTAL DISEASE, 2008, 10 (07) : 663 - 667
  • [7] The relationship between serum and tumoral CRP, Akt, MAPK, and survival in patients undergoing potentially curative resection for colorectal cancer
    Powell, Arfon
    Shepherd, Scott
    Orange, Clare
    Mcmillan, Donald C.
    Horgan, Paul G.
    Edwards, Joanne E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] The Relationship between an Inflammation Based Prognostic Score and Post Operative Complications in Patients Undergoing Potentially Curative Resection for Colorectal Cancer
    Moyes, L. H.
    McMillan, D. C.
    SCOTTISH MEDICAL JOURNAL, 2008, 53 (04) : 47 - 47
  • [9] The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer
    Canna, K
    McArdle, PA
    McMillan, DC
    McNicol, AM
    Smith, GW
    McKee, RF
    McArdle, CS
    BRITISH JOURNAL OF CANCER, 2005, 92 (04) : 651 - 654
  • [10] The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer
    K Canna
    P A McArdle
    D C McMillan
    A-M McNicol
    G W Smith
    R F McKee
    C S McArdle
    British Journal of Cancer, 2005, 92 : 651 - 654